Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-316

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 67457-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Decitabine Chemical Structure (Decitabine Chemical Structure)

FDA Label Image

Decitabine Carton Image (Decitabine Carton Image)

FDA Label Image

Decitabine Vial Image (Decitabine Vial Image)

Decitabine Vial Image (Decitabine Vial Image)
The text contains information about the drug Sile which is a combination of monobasic potassium phosphate and Decitabine Samyios. It provides information about its indications, dosage, and precautions. It also contains instructions on how to store the drug and a warning to discard the unused portion. The text also includes a chemical formula.*
FDA Label Image

Manufacturer Statement (Manufacturer Statement)

Manufacturer Statement (Manufacturer Statement)
This is a description for the medication called Mylan®. It is manufactured for Mylan Institutional LLC located in Morgantown, WV 26505 USA, and manufactured by Pharmascience Inc. located in Candiac, Quebec, J5R 1J1, Canada.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.